Cognitive decline and neurodegenerative changes in RA patients have been linked to neuroinflammation, blood–brain barrier (BBB) dysfunction, and possibly SAA-mediated amyloid deposition [23]. This evidence concerns the gene SAA2 and rheumatoid arthritis.